Michael Gutch

Insider Reports History

Location
Boston, MA
Signature
/s/ Jason Duncan, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Gutch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entasis Therapeutics Holdings Inc. Chief Financial Officer and Chief Business Officer Common Stock 168K $369K $2.20 18 Jan 2022 Direct
Entasis Therapeutics Holdings Inc. Chief Financial Officer and Chief Business Officer Employee Stock Option (Right to Buy) 43.5K 16 Jul 2021 Direct
ALBIREO PHARMA, INC. Director Stock Option (right to buy) 0 02 Mar 2023 Direct

Insider Reports Filed by Michael Gutch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALBO ALBIREO PHARMA, INC. 02 Mar 2023 7 $0 4 Director 02 Mar 2023, 15:51
ALBO ALBIREO PHARMA, INC. 24 Jun 2022 1 $0 4 Director 28 Jun 2022, 16:01
ETTX Entasis Therapeutics Holdings Inc. 18 Jan 2022 1 $0 4 Chief Financial Officer and Chief Business Officer 19 Jan 2022, 15:05
ETTX Entasis Therapeutics Holdings Inc. 02 Nov 2021 1 -$10.8K 4 CFO and Chief Business Officer 03 Nov 2021, 16:02
ETTX Entasis Therapeutics Holdings Inc. 19 Oct 2021 2 -$12K 4 Chief Financial Officer and Chief Business Officer 20 Oct 2021, 16:09
ETTX Entasis Therapeutics Holdings Inc. 16 Jul 2021 6 $0 4 Chief Financial Officer and Chief Business Officer 15 Feb 2022, 15:05
ALBO ALBIREO PHARMA, INC. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 16:04